From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods

NMR in Biomedicine

Volumn 11, Issue 4-5, 1998, Pages 148-156

  Hagberg, Gisela ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Classification; Magnetic resonance spectroscopy; Neoplasms; Pattern recognition; Review

Indexed keywords

ANALYTIC METHOD; ARTIFICIAL NEURAL NETWORK; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLUSTER ANALYSIS; COMPLEX FORMATION; DATA ANALYSIS; IMAGE PROCESSING; METHODOLOGY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE; PATTERN RECOGNITION; PRIORITY JOURNAL; REVIEW;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASMS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PATTERN RECOGNITION, AUTOMATED;

EID: 0031904449     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199806/08)11:4/5<148::AID-NBM511>3.0.CO;2-4     Document Type: Review

References (66)

1. Fossel E. T., Carr J. M. and Mc Donagh J. Detection of malignant tumours: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N. Engl. J. Med. 315, 1369-1376 (1986).
2. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 5, 303-324 (1992).
3. Leach M. O. Introduction to in vivo MRS of cancer: new perspectives and open problems. Anticancer Res. 16, 1503-1514 (1996).
4. Delikatny E. J., Russell P., Hunter J. C., Hancock R., Atkinson K. H., van Haaften-Day C. and Mountford C. E. Proton MR and human cervical neoplasia: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology 188, 791-796 (1993).
5. 1H MRS analysis of human brain tumors. Anticancer Res. 16, 1559-1564 (1996).
6. 1H NMR spectroscopy. J. Neurochem. 64, 1655-1661 (1995).
7. Russell P., Lean C. L., Delbridge L., May G. L., Dowd S. and Mountford C. E. Proton magnetic resonance and human thyroid neoplasia I: discrimination between benign and malignant neoplasms. Am. J. Med. 96, 383-388 (1994).
8. 31P nuclear magnetic resonance spectroscopy. Lipids 29, 359-364 (1994).
9. 1H NMR spectroscopy in vivo and in vitro. J. Comput. Assist. Tomogr. 18, 705-713 (1994).
10. Gill S. S., Thomas D. G. T., van Bruggen N., Gadian D. G., Peden C. J., Bell J. D., Cox I. J., Menon K. D., Iles R. A., Bryant D. J. and Coutts G. A. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 14, 497-504 (1990).
11. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn. Reson. Med. 24, 123-136 (1992).
12. 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles. Cancer 76, 1715-1723 (1995).
13. Vion-Dury J., Favre R., Sciaky M., Gonfort-Gouny S., Harlé J. R., Grazziani N., Viout P., Grisoli F. and Cozzone P. J. Graphic-aided study of metabolic modifications of plasma in cancer using proton magnetic resonance spectroscopy. NMR Biomed. 6, 58-65 (1993).
14. Kurhanewicz J., Vigneron D. B., Nelson S. J., Hricak H., MacDonald J. M., Konety B. and Narayan P. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45, 459-466 (1995).
15. 31P NMR phospholipid characterization of intracranial tumors. Brain Res. 649, 1-2 (1994).
16. Noble M., Gutowski N., Bevan K., Engel U., Linskey M., Urenjak J., Bhakoo K. and Williams S. From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage. Glia 15, 222-230 (1995).
17. Urenjak J., Williams S. R., Gadian D. G. and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989 (1993).
18. Florian C. L., Preece N. E., Bhakoo K. K., Williams S. R. and Noble M. D. Cell type specific fingerprinting of meningioma and meningeal cells by proton nuclear magnetic resonance spectroscopy. Cancer Res. 55, 420-427 (1995).
19. Gonfort-Gouny S., Vion-Dury J., Nicoli F., Dano P., Donnet A., Grazziani N., Gastaut J. L., Grisoli F. and Cozzone P. J. A multi-parametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J. Neurol. Sci. 118, 123-133 (1993).
20. Madi Z., Meier B. U. and Ernst R. R. Detection of cross peaks in two-dimensional NMR by cluster analysis. J. Magn. Reson. 72, 584-590 (1987).
21. Neidig K. P., Saffrich R., Lorenz M. and Kalbitzer H. R. J. Magn. Reson. 89, 543-555 (1990).
22. Pfändler P. and Bodenhausen G. Automated analysis of two-dimensional NMR spectra of mixtures by pattern recognition. J. Magn. Reson. 70 71-78 (1986).
23. 1H NMR spectra of complex oligosaccharides with artificial neural networks. Science 251, 522-544 (1991).
24. Spraul M., Neidig P., Klauck U., Kassler P., Holmes E., Nicholson J. K., Sweatman B. C., Salman S. R., Farrant R. D. and Rahr E. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. J. Pharm. Biomed. Anal. 12, 1215-1225 (1994).
25. 1H NMR spectra of urine using an artificial neural network. J. Pharm. Biomed. Anal. 13, 205-211 (1995).
26. 1H NMR spectra of urine. A nonlinear mapping approach to the classification of lexicological data. NMR Biomed. 3, 166-172 (1990).
27. Ghauri F. Y., Nicholson J. K., Sweatman B. C., Wood , Beddell C. R., Lindon J. C. and Cairns N. J. NMR spectroscopy of human post mortem cerebrospinal fluid-distinction of Alzheimers disease from control using pattern recognition and statistics. NMR Biomed. 6, 163-167 (1993).
28. Anthony M. L., Sweatman B. C., Beddell C. R., Lindon J. C. and Nicholson J. K. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton magnetic resonance spectra of urine. Molec. Pharmacol. 46, 199-211 (1994).
29. 13C NMR spectra using statistical pattern recognition and wavetets. Magn. Reson. Med. 35, 834-840 (1996).
30. 31P NMR spectroscopic data in myopathies. Magn. Reson. Med. 13, 216-227 (1990).
31. 1H Nuclear Magnetic Resonance spectroscopic data from human plasma. Anticancer Res. 16, 1473-1478 (1996).
32. Astion M. L. and Wilding P. Application of neural networks to the interpretation of laboratory data in cancer diagnosis. Clin. Chem. 38, 34-38 (1992).
33. Gartland K. P. R., Beddell C. R., Lindon J. C. and Nicholson J. K. A pattern recognition approach to the comparison of PMR and clinical chemical data for classification of nephrotoxicity. J. Pharm. Biomed. Anal. 8, 963-968 (1990).
34. Ghauri F. Y., Blackledge C. A., Glen R. C., Sweatman B. C., Lindon J. C., Beddell C. R., Wilson I. D. and Nicholson J. K. Quantitative structure-metabolism relationships for substituted benzoic acids in the rat. Computational chemistry, NMR spectroscopy and pattern recognition studies. Biochem. Pharmacol. 44, 1935-1946 (1992).
35. Preul M. C., Caramanos Z., Collins L. D., Villemure J. -G., Leblanc R., Olivier A., Pokrupa R. and Arnold D. L. Accurate, non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Medicine 2 323-325 (1996).
36. Tate A. R., Crabb S., Griffiths J. R., Howells S. I., Mazucco R. A., Rodrigues L. M. and Watson D. Lipid metabolite peaks in pattern recognition analysis of tumour in vivo MR spectra. Anticancer Res. 16, 1575-1580 (1996).
37. 1H Magnetic Resonance Spectroscopy of colon tissue. Anticancer Res. 16, 1553-1558 (1996).
38. 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn. Reson. Med. 29, 436-440, (1993).
39. 1H MR spectra from untreated and recurrent ovarian cancer using linear discriminant analysis. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1692 (1995).
40. Hagberg G., Burlina A. P., Mader I., Roser W., Radue E. W. and Seelig J. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magn. Reson. Med. 34 242-252 (1995).
41. 1H MRS and multidimensional metabolic classification. MAGMA 5, (in press) (1997).
42. 1H nuclear magnetic resonance spectra by the application of chemometric techniques. Magn. Reson. Med. 28, 214-236 (1992).
43. 1H NMR spectra by pattern recognition. NMR Biomed. 5, 59-64 (1992).
44. 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy. J. Magn. Reson. Imag. 6, 437-444 (1996).
45. 1H MRS and multivariate analysis. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1691 (1995).
46. 1H spectra of thyroid neoplasms. Magn. Reson. Med. 33, 257-263 (1995).
47. 31P magnetic resonance spectroscopy tumour spectra obtained in vivo. NMR Biomed. 6, 237-241 (1993).
48. Branston N. M., Maxwell R. J. and Howells S. L. Generalization performance using backpropagation algorithms applied to patterns derived from tumour MR spectra. J. Microcomp. Appl. 16, 113-123 (1993).
49. 1H magnetic resonance spectroscopic phenotypes. Neuroreport 7 1597-1600 (1996).
50. 1H NMR spectra form human brain tumour biopsies. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1709 (1995).
51. 1H NMR spectra of human blood plasma. Society for Magnetic Resonance, 4th Annual Meeting. Abstr., p. 1170 (1996).
52. Fluge Ø, Gilje K. S., Sletten E., Kvalheim O. M., Skaarland E., Halvorsen J. F., Farstad M. and Søreide O. Proton nuclear magnetic resonance spectroscopy of serum from patients with colorectal neoplasia. Europ. J. Surg. Oncol. 22, 78-83 (1996).
53. Derr T., Monnerjahn J., Els T., Gyngell M. and Leibfritz D. A novel classification strategy for the robust analysis of proton NMR spectra of tissue extracts from tumorous rat brain. Society for Magnetic Resonance, 5th Annual Meeting. Abstr., p. 497 (1997).
54. Dwarakanath S., Ferris C. D. d., Pierre J. W., Asplund R. O. and Curtis D. L. A neural network approach to the early detection of cancer. Biomed. Sci. Instrum. 30, 239-243 (1994).
55. 31P MRS acquisition of working rat muscle. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1954 (1995).
56. Neue G. Simplification of dynamic NMR spectroscopy by wavelet transforms. Solid State Nucl. Magn. Reson. 5, 305-314 (1996).
57. Hamamoto Y., Kanaoka T. and Tomita S. On a theoretical comparison between the orthonormal discriminant vector method and discriminant analysis. Pattern Recognition 26, 1863-1867 (1993).
58. Fukunaga K. Introduction to statistical Pattern Recognition. 2nd edn, Academic Press, San Diego (1990).
59. Nikulin A., Brière K. M., Friesen L., Smith I. C. P. and Somorjai R. L. Genetic algorithm-guided optimal attribute selection: a novel preprocessor for classifying MR spectra. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1940 (1995).
60. Dolenko B. and Somorjai R. L. Time well spent: pre-processing of MR spectra for greater classification accuracy. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1936 (1995).
61. Pizzi N. and Somorjai R. To burnish tarnished gold standards: a classification strategy for MR spectra as applied to human brain neoplasm diagnosis. Society for Magnetic Resonance, 3rd Annual Meeting. Abstr., p. 1937 (1995).
62. Pizzi N. Robust adjustment of tarnished gold standards: classifying MR spectra of human brain neoplasms. Society for Magnetic Resonance, 5th Annual Meeting. Abstr., p. 1377 (1997).
63. 1H MR spectra. Society for Magnetic Resonance, 5th Annual Meeting. Abstr., p. 1939 (1995).
64. Tyszka J. M., Terk M. R. and Pressman B. Self-organizing neural networks for classification of short echo time in vivo proton NMR spectra Society for Magnetic Resonance, 5th Annual Meeting. Abstr., p. 1950 (1995).
65. Tate A. R. Statistical pattern recognition for the analysis of biomedical magnetic resonance spectra. J. Magn. Reson. Anal. 3, 63-78 (1996).
66. Massart D. L., Vandeginste B. G. M., Deming S. N., Michotte Y. and Kaufman L. Chemometrics: A Textbook. Elsevier Science Publications (1988).